Puts NAJ, Wodka EL, Harris AD, Crocetti D, Tommerdahl M, Mostofsky SH, Edden RAE. Reduced GABA and altered somatosensory function in children with autism spectrum disorder. Autism Res. 2017;10(4):608–19. https://doi.org/10.1002/aur.1691. Epub 2016 Sep 9.
Parrella NF, Hill AT, Dipnall LM, Loke YJ, Enticott PG, Ford TC. Inhibitory dysfunction and social processing difficulties in autism: a comprehensive narrative review. J Psychiatr Res. 2024;169:113–25. Epub 2023 Nov 18.
Havranek T, Bacova Z, Bakos J. Oxytocin, GABA, and dopamine interplay in autism. Endocr Regul. 2024;58(1):105–14. https://doi.org/10.2478/enr-2024-0012
Zhu Y, Li H, Zhou L, Wu JY, Rao Y. Cellular and molecular guidance of GABAergic neuronal migration from an extracortical origin to the neocortex. Neuron. 1999;23(3):473–85. https://doi.org/10.1016/s0896-6273(00)80801-6
Tang X, Jaenisch R, Sur M. The role of GABAergic signalling in neurodevelopmental disorders. Nat Rev Neurosci. 2021;22(5):290–307. https://doi.org/10.1038/s41583-021-00443-x. Epub 2021 Mar 26.
Bouarab C, Thompson B, Polter AM. VTA GABA neurons at the interface of stress and reward. Front Neural Circuits. 2019;13:78. https://doi.org/10.3389/fncir.2019.00078
Root DH, Barker DJ, Estrin DJ, Miranda-Barrientos JA, Liu B, Zhang S, Wang HL, Vautier F, Ramakrishnan C, Kim YS, Fenno L, Deisseroth K, Morales M. Distinct signaling by ventral tegmental area glutamate, GABA, and combinatorial Glutamate-GABA neurons in motivated behavior. Cell Rep. 2020;32(9):108094. https://doi.org/10.1016/j.celrep.2020.108094
Chuhma N, Oh SJ, Rayport S. The dopamine neuron synaptic map in the striatum. Cell Rep. 2023;42(3):112204. https://doi.org/10.1016/j.celrep.2023.112204. Epub 2023 Mar 2. PMID: 36867530; PMCID: PMC10657204.
Faget L, Oriol L, Lee WC, Zell V, Sargent C, Flores A, Hollon NG, Ramanathan D, Hnasko TS. Ventral pallidum GABA and glutamate neurons drive approach and avoidance through distinct modulation of VTA cell types. Nat Commun. 2024;15(1):4233. https://doi.org/10.1038/s41467-024-48340-y
Peça J, Feliciano C, Ting JT, Wang W, Wells MF, Venkatraman TN, Lascola CD, Fu Z, Feng G. Shank3 mutant mice display autistic-like behaviours and striatal dysfunction. Nature. 2011;472(7344):437–42. https://doi.org/10.1038/nature09965. Epub 2011 Mar 20.
Bey AL, Wang X, Yan H, Kim N, Passman RL, Yang Y, Cao X, Towers AJ, Hulbert SW, Duffney LJ, Gaidis E, Rodriguiz RM, Wetsel WC, Yin HH, Jiang YH. Brain region-specific disruption of Shank3 in mice reveals a dissociation for cortical and striatal circuits in autism-related behaviors. Transl Psychiatry. 2018;8(1):94. https://doi.org/10.1038/s41398-018-0142-6
Reichova A, Bacova Z, Bukatova S, Kokavcova M, Meliskova V, Frimmel K, Ostatnikova D, Bakos J. Abnormal neuronal morphology and altered synaptic proteins are restored by oxytocin in autism-related SHANK3 deficient model. Mol Cell Endocrinol. 2020;518:110924. https://doi.org/10.1016/j.mce.2020.110924. Epub 2020 Jun 30.
Bukatova S, Renczes E, Reichova A, Filo J, Sadlonova A, Mravec B, Ostatnikova D, Bakos J, Bacova Z. Shank3 deficiency is associated with altered profile of neurotransmission markers in pups and adult mice. Neurochem Res. 2021;46(12):3342–55. https://doi.org/10.1007/s11064-021-03435-6. Epub 2021 Aug 28.
Mihalj D, Borbelyova V, Pirnik Z, Bacova Z, Ostatnikova D, Bakos J. Shank3 deficiency results in a reduction in GABAergic postsynaptic puncta in the olfactory brain areas. Neurochem Res. 2024;49(4):1008–16. https://doi.org/10.1007/s11064-023-04097-2. Epub 2024 Jan 6.
Bhandage AK, Friedrich LM, Kanatani S, Jakobsson-Björkén S, Escrig-Larena JI, Wagner AK, Chambers BJ, Barragan A. GABAergic signaling in human and murine NK cells upon challenge with toxoplasma gondii. J Leukoc Biol. 2021;110(4):617–28. https://doi.org/10.1002/JLB.3HI0720-431R. Epub 2021 May 24.
Arsenault J, Gholizadeh S, Niibori Y, Pacey LK, Halder SK, Koxhioni E, Konno A, Hirai H, Hampson DR. FMRP expression levels in mouse central nervous system neurons determine behavioral phenotype. Hum Gene Ther. 2016;27(12):982–96. https://doi.org/10.1089/hum.2016.090
Du Z, Tertrais M, Courtand G, Leste-Lasserre T, Cardoit L, Masmejean F, Halgand C, Cho YH, Garret M. Differential alteration in expression of striatal GABAAR subunits in mouse models of Huntington’s disease. Front Mol Neurosci. 2017;10:198. https://doi.org/10.3389/fnmol.2017.00198
Yoon S, Choi YC, Lee S, Jeong Y, Yoon J, Baek K. Induction of growth arrest by mir-542-3p that targets survivin. FEBS Lett. 2010;584(18):4048–52. https://doi.org/10.1016/j.febslet.2010.08.025
Bottermann M, Foss S, Caddy SL, Clift D, van Tienen LM, Vaysburd M, Cruickshank J, O’Connell K, Clark J, Mayes K, Higginson K, Lode HE, McAdam MB, Sandlie I, Andersen JT, James LC. Complement C4 prevents viral infection through capsid inactivation. Cell Host Microbe. 2019;25(4):617–e6297. https://doi.org/10.1016/j.chom.2019.02.016
Sato M, Nakai N, Fujima S, Choe KY, Takumi T. Social circuits and their dysfunction in autism spectrum disorder. Mol Psychiatry. 2023;28(8):3194–206. https://doi.org/10.1038/s41380-023-02201-0. Epub 2023 Aug 24.
Cai J, Tong Q. Anatomy and function of ventral tegmental area glutamate neurons. Front Neural Circuits. 2022;16:867053. https://doi.org/10.3389/fncir.2022.867053
Chowdhury S, Matsubara T, Miyazaki T, Ono D, Fukatsu N, Abe M, Sakimura K, Sudo Y, Yamanaka A. GABA neurons in the ventral tegmental area regulate non-rapid eye movement sleep in mice. Elife. 2019;8:e44928. https://doi.org/10.7554/eLife.44928
Gantz SC, Bunzow JR, Williams JT. Spontaneous inhibitory synaptic currents mediated by a G protein-coupled receptor. Neuron. 2013;78(5):807–12. https://doi.org/10.1016/j.neuron.2013.04.013
Morales M, Margolis EB. Ventral tegmental area: cellular heterogeneity, connectivity and behaviour. Nat Rev Neurosci. 2017;18(2):73–85. https://doi.org/10.1038/nrn.2016.165
Wang YZ, Perez-Rosello T, Smukowski SN, Surmeier DJ, Savas JN. Neuron type-specific proteomics reveals distinct Shank3 proteoforms in iSPNs and dSPNs lead to striatal synaptopathy in Shank3B-/- mice. Mol Psychiatry. 2024 Mar 14. https://doi.org/10.1038/s41380-024-02493-w. Epub ahead of print. Erratum in: Mol Psychiatry. 2024 Mar 28. https://doi.org/10.1038/s41380-024-02543-3.
Li W, Pozzo-Miller L. Dysfunction of the corticostriatal pathway in autism spectrum disorders. J Neurosci Res. 2020;98(11):2130–47. https://doi.org/10.1002/jnr.24560. Epub 2019 Nov 22.
Jaramillo TC, Speed HE, Xuan Z, Reimers JM, Liu S, Powell CM. Altered striatal synaptic function and abnormal behaviour in Shank3 Exon4-9 deletion mouse model of autism. Autism Res. 2016;9(3):350–75. https://doi.org/10.1002/aur.1529. Epub 2015 Nov 11.
Lee V, Maguire J. The impact of tonic GABAA receptor-mediated inhibition on neuronal excitability varies across brain region and cell type. Front Neural Circuits. 2014;8:3. https://doi.org/10.3389/fncir.2014.00003. PMID: 24550784; PMCID: PMC3909947.
Sassoè-Pognetto M, Panzanelli P, Sieghart W, Fritschy JM. Colocalization of multiple GABA(A) receptor subtypes with gephyrin at postsynaptic sites. J Comp Neurol. 2000;420(4):481–98.
Tretter V, Mukherjee J, Maric HM, Schindelin H, Sieghart W, Moss SJ. Gephyrin, the enigmatic organizer at GABAergic synapses. Front Cell Neurosci. 2012;6:23. https://doi.org/10.3389/fncel.2012.00023
George S, Bear J Jr, Taylor MJ, Kanamalla K, Fekete CD, Chiou TT, Miralles CP, Papadopoulos T, De Blas AL. Collybistin SH3-protein isoforms are expressed in the rat brain promoting gephyrin and GABA-A receptor clustering at GABAergic synapses. J Neurochem. 2021;157(4):1032–51. https://doi.org/10.1111/jnc.15270
Machado CO, Griesi-Oliveira K, Rosenberg C, Kok F, Martins S, Passos-Bueno MR, Sertie AL. Collybistin binds and inhibits mTORC1 signaling: a potential novel mechanism contributing to intellectual disability and autism. Eur J Hum Genet. 2016;24(1):59–65. https://doi.org/10.1038/ejhg.2015.69
Chiou TT, Long P, Schumann-Gillett A, Kanamarlapudi V, Haas SA, Harvey K, O’Mara ML, De Blas AL, Kalscheuer VM, Harvey RJ. Mutation p.R356Q in the collybistin phosphoinositide binding site is associated with mild intellectual disability. Front Mol Neurosci. 2019;12:60. https://doi.org/10.3389/fnmol.2019.00060
Melzer S, Monyer H. Diversity and function of corticopetal and corticofugal GABAergic projection neurons. Nat Rev Neurosci. 2020;21(9):499–515. https://doi.org/10.1038/s41583-020-0344-9. Epub 2020 Aug 3.
Huang G, Chen S, Chen X, Zheng J, Xu Z, Doostparast Torshizi A, Gong S, Chen Q, Ma X, Yu J, Zhou L, Qiu S, Wang K, Shi L. Uncovering the functional link between SHANK3 deletions and deficiency in neurodevelopment using iPSC-derived human neurons. Front Neuroanat. 2019;13:23. https://doi.org/10.3389/fnana.2019.00023
Filice F, Vörckel KJ, Sungur AÖ, Wöhr M, Schwaller B. Reduction in parvalbumin expression not loss of the parvalbumin-expressing GABA interneuron subpopulation in genetic parvalbumin and shank mouse models of autism. Mol Brain. 2016;9:10. https://doi.org/10.1186/s13041-016-0192-8
Dufour BD, McBride E, Bartley T, Juarez P, Martínez-Cerdeño V. Distinct patterns of GABAergic interneuron pathology in autism are associated with intellectual impairment and stereotypic behaviors. Autism. 2023;27(6):1730–45. https://doi.org/10.1177/13623613231154053
Add Comment